Tumor Markers in Diagnosis (CEA, AFP, PSA)
Start with the big picture
Tumor markers are serum molecules associated with some malignancies, but benign conditions can also raise their levels. CEA is associated with several cancers, especially colorectal cancer, and serial values can help monitor for recurrence; smoking and inflammatory or liver conditions may affect results. AFP is linked to hepatocellular carcinoma and certain non-seminomatous germ-cell tumors, and maternal AFP screening has a distinct role in assessing pregnancy-related risks. PSA is specific to the prostate rather than to cancer, so benign prostatic conditions can also elevate it. The lesson emphasizes interpreting marker results alongside clinical assessment and other investigations, and using marker kinetics—not isolated values alone—to evaluate response or possible recurrence.
What you'll learn
- Explain why tumor markers cannot diagnose cancer on their own.
- Describe the main cancer associations and limitations of CEA, AFP, and PSA.
- Recognize benign conditions and other contexts that may affect marker levels.
- Explain how serial measurements and marker kinetics support monitoring.
- Summarize the role of maternal serum AFP screening.
Continue your study
Work through the complete notes and reinforce the topic with the study tools available in the full lesson.